KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Interest Expenses (2016 - 2017)

Historic Interest Expenses for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Q4 2017 value amounting to -$703999.1 billion.

  • Teva Pharmaceutical Industries' Interest Expenses fell 9060487799.23% to -$703999.1 billion in Q4 2017 from the same period last year, while for Sep 2018 it was -$703999.1 billion, marking a year-over-year decrease of 24164.94%. This contributed to the annual value of $934.0 million for FY2025, which is 479.1% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Interest Expenses of -$703999.1 billion as of Q4 2017, which was down 9060487799.23% from $259000.0 billion recorded in Q3 2017.
  • Teva Pharmaceutical Industries' 5-year Interest Expenses high stood at $259000.0 billion for Q3 2017, and its period low was -$703999.1 billion during Q4 2017.
  • In the last 5 years, Teva Pharmaceutical Industries' Interest Expenses had a median value of $132.0 million in 2013 and averaged $2400.2 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Interest Expenses skyrocketed by 25609746097.56% in 2016 and then crashed by 9060487799.23% in 2017.
  • Over the past 5 years, Teva Pharmaceutical Industries' Interest Expenses (Quarter) stood at $59.0 million in 2013, then grew by 18.64% to $70.0 million in 2014, then changed by 0.0% to $70.0 million in 2015, then skyrocketed by 1010.0% to $777.0 million in 2016, then tumbled by 90604877.99% to -$703999.1 billion in 2017.
  • Its Interest Expenses was -$703999.1 billion in Q4 2017, compared to $259000.0 billion in Q3 2017 and $238000.0 billion in Q2 2017.